Latest news
Big Brother Comes to Southeast Asia - Asia SentinelAsia Sentinel · Fri, 07 Aug 2026 01:51:28 GMTSeres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 14:41:21 GMTMCRB: Net loss of $42.2M and cash of $15.6M highlight urgent need for new funding by Q1 2027 - TradingViewTradingView · Wed, 05 Aug 2026 14:31:46 GMTSeres Therapeutics (MCRB) Q2 Revenue Surpasses Expectations Amid Clinical Progress - GuruFocusGuruFocus · Wed, 05 Aug 2026 13:03:49 GMTSeres Therapeutics Q2 net income turns positive on VOWST sale gain - TradingViewTradingView · Wed, 05 Aug 2026 11:19:30 GMTSeres Therapeutics reports Q2 2026 net income of $4.6M, cash $15.6M, advances SER-155 clinical plans - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMTMCRB: Returned to profitability in Q2 2026, driven by VOWST sale gains and SER-155 trial success - TradingViewTradingView · Wed, 05 Aug 2026 11:12:40 GMTSeres Reports 80% Response in Colitis Linked to Cancer Therapy - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMT